14th International Conference on Generic Drugs and Biosimilars 2018

The 14th International Conference on Generic Drugs and Biosimilars 2018 covers topics such as:

• Biosimilar and biologics
• Generic drugs, generic pills and generic medication
• Biosimilars uptake and patient safety
• Pharmacovigilance and safety of biosimilars
• Protein biotherapeutics and biosimilars
• Generics and biosimilars industry strategy
• Biosimilar development challenges
• Developing biosimilars and biobetters
• Case study mitigating risk in biosimilar development
• Pharmacology and drug developement
• Array of clinical trials in biosimilars
• Quality control and R&D
• Pharma pricing and market access
• Patent access and intellectual property and FDA regulations
• Chronicles of biosimilar production facility
• Licensing, manufacturing and health economics
• Innovation and technology for biosimilar development
• Global generic trends and global pharma market
• GMP, GCP and quality control
• Biosimilars differentiated through novel drug delivery technologies
• Entrepreneurs investment meet
• Office of generic drugs (OGD)